| S2824 |
TPCA-1 |
TPCA-1 is an inhibitor of IKK-2 with IC50 of 17.9 nM, inhibits NF-κB pathway, exhibits 22-fold selectivity over IKK-1. |
Selective |
IKK2, IC50: 17.9 nM |
| S2882 |
IKK-16 (IKK Inhibitor VII) |
IKK-16 (IKK Inhibitor VII) is a selective IκB kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively. |
Selective |
IKK complex, IC50: 70 nM; IKK2, IC50: 40 nM; IKK1, IC50: 200 nM |
| S8044 |
BMS-345541 |
BMS-345541 is a highly selective inhibitor of the catalytic subunits of IKK-2 and IKK-1 with IC50 of 0.3 μM and 4 μM, respectively. |
Selective |
IKK1, IC50: 4 μM; IKK2, IC50: 0.3 μM; IKK1, IC50: 4 μM; IKK2, IC50: 0.3 μM; IKK1, IC50: 4 μM; IKK2, IC50: 0.3 μM |
| S4907 |
SC-514 |
SC-514 is an orally active, ATP-competitive IKK-2 inhibitor with IC50 of 3-12 μM, blocks NF-κB-dependent gene expression, does not inhibit other IKK isoforms or other serine-threonine and tyrosine kinases. |
Selective |
IKK2, IC50: 3 μM-12 μM |
| S7441 |
WS3 |
WS3 is a β cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the IκB kinase pathway.
|
Selective |
|
| S7442 |
WS6 |
WS6 is a β cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the IκB kinase pathway.
|
Selective |
|
| S2864 |
IMD 0354 |
IMD-0354 is an IKKβ inhibitor and blocks IκBα phosphorylation in NF-κB pathway. |
Selective |
|
| S8078 |
Bardoxolone Methyl |
Bardoxolone Methyl is an IKK inhibitor, showing potent proapoptotic and anti-inflammatory activities. Phase 3. |
Selective |
|
| S1274 |
BX-795 |
BX795 is a potent and specific PDK1 inhibitor with IC50 of 6 nM, 140- and 1600-fold more selective for PDK1 than PKA and PKC, respectively. Meanwhile, in comparison to GSK3β more than 100-fold selectivity observed for PDK1. |
Selective |
|